Td Private Client Wealth LLC Kodiak Sciences Inc. Transaction History
Td Private Client Wealth LLC
- $3.18 Trillion
- Q2 2024
Shares
2 transactions
Others Institutions Holding KOD
# of Institutions
104Shares Held
40.3MCall Options Held
7.6KPut Options Held
3.5K-
Baker Bros. Advisors LP New York, NY17.3MShares$92.4 Million0.54% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$20.5 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.95MShares$10.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$8.84 Million0.0% of portfolio
-
Silverarc Capital Management, LLC1.06MShares$5.67 Million0.71% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $278M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...